Clinical Trials in Caguas, Puerto Rico
2 recruiting
Showing 1–2 of 2 trials
Recruiting
Phase 3
Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Recent ACS
Acute Coronary Syndrome
DalCor Pharmaceuticals2,000 enrolled223 locationsNCT05918861
Recruiting
Phase 2
A Study of Obexelimab in Patients With Systemic Lupus Erythematosus
Systemic Lupus Erythematosus
Zenas BioPharma (USA), LLC190 enrolled82 locationsNCT06559163